Growth Hormone Study in Adults With Prader-Willi Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The overall objective of this study is to measure the effect of growth hormone (GH) treatment on physical and psychosocial health in adults with Prader-Willi syndrome. Adults with PWS who have not been treated with GH during the past three years and who will start with GH treatment as part of regular patient care will be asked for informed consent to participate in this open-label prospective cohort study. We hypothesize that growth hormone treatment will improve the physical and psychosocial health.
Epistemonikos ID: f80edb08b4f95ab0fc58badd93c065d7926ce862
First added on: May 07, 2024